Generated: May 23, 2017
|Title:||Ophthalmic use of norfloxacin and related antibiotics|
|Abstract:||Norfloxacin and related antibiotics are useful in the treatment of ocular infections by topical administration.|
|Inventor(s):||Katz; Irving M. (Doylestown, PA)|
|Assignee:||Merck & Co., Inc. (Rahway, NJ)|
1. A method of treating ocular bacterial infections which comprises topical ocular administration to an infected eye, of 0.015-1.5 mg of an antibiotic selected from
norfloxacin, ofloxacin, pefloxacin, AT-2266 and Bayer 09867, hydrates or ophthalmologically acceptable salts thereof.
2. The method of claim 1 wherein the antibiotic is norfloxacin, a hydrate or ophthalmologically acceptable salt thereof.
3. The method of claim 2 wherein the norfloxacin is administered as an aqueous solution.
4. The method of claim 1 wherein the carrier is a clear physiologically-acceptable liquid which forms a semi-solid gel at human body temperatures.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.